Publication & Citation Trends
Publications
0 total
Metabolism and Excretion pathways of CD388, a novel drug-Fc conjugate for prevention of seasonal or pandemic influenza
Cited by 0
Semantic Scholar
227. A Randomized, Placebo-controlled Trial to Evaluate the Safety and Efficacy of CD388, a Novel Drug-Fc-Conjugate, for Prevention of Illness due to Influenza A and B in Healthy Unvaccinated Participants
Cited by 0
Semantic Scholar
Drug–Fc conjugate CD388 targets influenza virus neuraminidase and is broadly protective in mice OA
Cited by 10
Semantic Scholar
Abstract 2668: CBO421: A novel drug Fc-conjugate to prevent tumor immune evasion via the CD73/adenosine pathway
Cited by 1
Semantic Scholar
Abstract 2731: CCR5-001, a novel drug Fc-conjugate (DFC) targeting CCR5, demonstrates potent efficacy in a colorectal cancer mouse model
Cited by 0
Semantic Scholar
Abstract 2728: Discovery of a multispecific CD73/PD-1 targeting drug Fc-conjugate (DFC), which improves tumor reduction compared to PD-1 monotherapy in a humanized mouse model
Cited by 0
Semantic Scholar
CD388: A universally protective Drug-Fc Conjugate that targets influenza virus neuraminidase OA
Cited by 1
Semantic Scholar
Abstract LB131: CBO421, a novel drug Fc-conjugate, inhibits the enzymatic activity of CD73 and triggers CD73 internalization
Cited by 2
Semantic Scholar
Research Topics
Enzyme Structure and Function
(12)
Bacterial Genetics and Biotechnology
(9)
Porphyrin Metabolism and Disorders
(8)
Biochemical and Molecular Research
(6)
Iron Metabolism and Disorders
(5)
Affiliations
University of Calgary
University of Saskatchewan
ActiveSite Pharmaceuticals (United States)
Mirati Therapeutics (United States)
Advanced Coherent Technologies (United States)